Jeremy T. Blitzer
Rapt Therapeutics (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Cellular transport and secretion, Ion Transport and Channel Regulation, HER2/EGFR in Cancer Research, Estrogen and related hormone effects
Most-Cited Works
- → The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange(1998)580 cited
- → A C-terminal motif found in the β 2 -adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na + /H + exchanger regulatory factor family of PDZ proteins(1998)402 cited
- → A critical role for endocytosis in Wnt signaling(2006)223 cited
- → Platelet-Derived Growth Factor Receptor Association with Na+/H+ Exchanger Regulatory Factor Potentiates Receptor Activity(2000)204 cited
- → G Protein-coupled Receptor Kinase 6A Phosphorylates the Na+/H+ Exchanger Regulatory Factor via a PDZ Domain-mediated Interaction(1999)140 cited
- → The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer(2019)91 cited
- → Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy(2019)55 cited
- → PAS Kinase Drives Lipogenesis through SREBP-1 Maturation(2014)40 cited
- → Physiological Modulation of Rabphilin Phosphorylation(2001)36 cited
- → DES1: A Key Driver of Lipotoxicity in Metabolic Disease(2020)15 cited